We are live on ! Find out more
IIM

INTECH Investment Management Portfolio holdings

AUM $10.2B
1-Year Est. Return 28.14%
This Fund
S&P 500
This Quarter Est. Return
-4.74%
1 Year Est. Return
+28.14%
3 Year Est. Return
+94.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.7B
AUM Growth
-$615M
Cap. Flow
+$46.7M
Cap. Flow %
0.48%
Top 10 Hldgs %
23.8%
Holding
2,583
New
206
Increased
1,731
Reduced
552
Closed
62

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$68.5M
2
MRK icon
Merck
MRK
+$58.7M
3
SMDX
Intech S&P Small-Mid Cap Diversified Alpha ETF
SMDX
+$53.4M
4
TSLA icon
Tesla
TSLA
+$51.6M
5
AVGO icon
Broadcom
AVGO
+$49.5M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$50.7M
2
PGR icon
Progressive
PGR
+$46M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$41.3M
4
CTAS icon
Cintas
CTAS
+$40.1M
5
CEG icon
Constellation Energy
CEG
+$36.2M

Sector Composition

Rank Sector Weight
1 Technology 25.32%
2 Financials 14.34%
3 Healthcare 13.01%
4 Consumer Discretionary 10.83%
5 Industrials 9.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLVX
2476
DELISTED
HilleVax
HLVX
$31.5K ﹤0.01%
21,756
+9,109
+72% +$16.8K
PYXS icon
2477
Pyxis Oncology
PYXS
$243M
$31.5K ﹤0.01%
32,173
+9,682
+43% +$12.9K
ABOS icon
2478
Acumen Pharmaceuticals
ABOS
$173M
$31.4K ﹤0.01%
28,540
+9,693
+51% +$13.8K
MRSN
2479
DELISTED
Mersana Therapeutics
MRSN
$31.1K ﹤0.01%
3,614
+1,573
+77% +$24.3K
TPIC
2480
DELISTED
TPI Composites
TPIC
$30.5K ﹤0.01%
37,879
+15,405
+69% +$20.1K
INO icon
2481
Inovio Pharmaceuticals
INO
$74.2M
$30.1K ﹤0.01%
18,441
+6,434
+54% +$12.9K
GUTS icon
2482
Fractyl Health
GUTS
$111M
$29.9K ﹤0.01%
25,154
+8,740
+53% +$14K
PRPL icon
2483
Purple Innovation
PRPL
$39.2M
$29.7K ﹤0.01%
+1,563
New +$36K
SKYE icon
2484
Skye Bioscience
SKYE
$18.5M
$29.1K ﹤0.01%
+18,278
New +$49.9K
APLT
2485
DELISTED
Applied Therapeutics
APLT
$28.1K ﹤0.01%
57,524
+4,893
+9% +$2.88K
ZYXI
2486
DELISTED
Zynex
ZYXI
$27.6K ﹤0.01%
+12,562
New +$82K
MRDN
2487
Meridian Holdings Inc
MRDN
$179M
$27.2K ﹤0.01%
+1,150
New +$27.9K
STTK icon
2488
Shattuck Labs
STTK
$688M
$27.2K ﹤0.01%
28,599
+10,587
+59% +$13K
CLYM
2489
Climb Bio
CLYM
$786M
$25.6K ﹤0.01%
21,022
+7,321
+53% +$11.9K
TNYA icon
2490
Tenaya Therapeutics
TNYA
$163M
$25.6K ﹤0.01%
44,960
+17,032
+61% +$16.8K
AKYA
2491
DELISTED
Akoya BioSciences
AKYA
$25.4K ﹤0.01%
18,262
+6,482
+55% +$14.2K
RDZN icon
2492
Roadzen
RDZN
$107M
$24.9K ﹤0.01%
+23,941
New +$32.2K
PEPG icon
2493
PepGen
PEPG
$199M
$24.8K ﹤0.01%
+17,626
New +$36.3K
LNAI
2494
Lunai Bioworks
LNAI
$10.9M
$24.4K ﹤0.01%
+561
New +$35.9K
LNZA icon
2495
LanzaTech
LNZA
$68.1M
$24.3K ﹤0.01%
1,005
+451
+81% +$40.6K
LCTX icon
2496
Lineage Cell Therapeutics
LCTX
$288M
$23K ﹤0.01%
+50,922
New +$29.9K
CBUS icon
2497
Cibus
CBUS
$150M
$22.3K ﹤0.01%
+11,910
New +$27.9K
HOWL icon
2498
Werewolf Therapeutics
HOWL
$19M
$21.6K ﹤0.01%
22,239
+7,373
+50% +$9.65K
ACRV icon
2499
Acrivon Therapeutics
ACRV
$74.5M
$20.5K ﹤0.01%
+10,091
New +$54.3K
HBIO icon
2500
Harvard Bioscience
HBIO
$29.6M
$20.3K ﹤0.01%
3,591
+1,911
+114% +$24.5K
98 99
100
101 102

Similar funds

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

INTECH Investment Management's Q1 2025 Portfolio in Review

As of Q1 2025, INTECH Investment Management held 2,583 positions worth $9.7B, down 6% from $10.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

INTECH Investment Management's Q1 2025 filing shows 206 new, 1,731 increased, 552 reduced and 62 closed positions. Its largest new stake was Intech S&P Small-Mid Cap Diversified Alpha ETF: 2,762,981 shares worth $53.5M. The largest sale was Eli Lilly, an estimated $50.7M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Financials and Healthcare.

  • INTECH Investment Management's largest Q1 2025 buy was Intech S&P Small-Mid Cap Diversified Alpha ETF: 2,762,981 shares worth $53.5M.
  • INTECH Investment Management added most to Amazon in Q1 2025, an estimated $68.5M increase.
  • INTECH Investment Management's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $50.7M.
  • INTECH Investment Management fully exited Teleflex in Q1 2025, selling an estimated $7.45M.
  • INTECH Investment Management's ten largest holdings make up 24% of its $9.7B portfolio in Q1 2025.
  • INTECH Investment Management opened 206 new positions and closed 62 in Q1 2025.
  • INTECH Investment Management's portfolio value fell 6% quarter-over-quarter to $9.7B.

Based on INTECH Investment Management's 13F filing for Q1 2025, filed 20 May 2025.